Remove Events Remove Pharmaceutical Companies Remove Vaccines
article thumbnail

Pharma ‘must not dodge liability for harm in COVID-19 vaccine trials’

pharmaphorum

An EU consumer body has urged the European Commission to keep compensation measures in place for people who might be harmed in COVID-19 vaccine trials, responding to reports that the drug industry is lobbying to reduce liability. The BEUC is adamant that relaxing consumer protections even in such exceptional circumstances is a bad idea.

Vaccines 120
article thumbnail

The Pandemic Treaty and the opportunity to end ‘vaccine apartheid’

pharmaphorum

Ben Hargreaves discovers why some have referred to the distribution of COVID-19 vaccines and treatments as a form of apartheid. There are already rules that dictate how countries should react against public health events that have the potential to traverse country borders, through the International Health Regulations. Reacting faster.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

STAT+: Pharmalittle: Europe regulator raised safety signal on Novo drugs; U.S. seeks new trial over royalties on Gilead HIV prevention pills

STAT

Hope you have a smashing day and, of course, do stay in touch … Leaders of European pharmaceutical companies argued that a proposed overhaul of European Union policies could render the industry less competitive, the latest step in their opposition to legislation that could shorten exclusivity periods for selling drugs, STAT writes.

article thumbnail

Scientific evidence ‘on demand’? Proceedings from an expert roundtable

pharmaphorum

The cancellation of live events in 2020 has demanded a different means of data communication. An excellent example of this is COVID-19 vaccine trial data; press releases are eagerly followed in almost real-time by HCPs and the public alike. Q1: What are some ways in which data dissemination has evolved in 2020? Conclusion.

article thumbnail

Valuable virtual tools to keep HCPs informed

pharmaphorum

If there’s one take-home message about working during a pandemic, it is the enormous value that virtual events, webinars and e-learning can bring when face-to-face meetings and presentations are impossible. Rewind to March of 2020, and pharma companies were facing a communication crisis. The crisis that changed everything.

article thumbnail

Digital success for pharma services in a uncertain world

pharmaphorum

Additionally, it is hard for companies to determine which initiatives they should scale up and which will add most value in the long-term, as often there is a long time before return on investment is generated. Smart use of data can help companies focus on the events they can plan for, but also predict and respond to those they cannot”.

article thumbnail

How to address patient vaccine hesitancy and misconceptions

The Checkup by Singlecare

Vaccines have been an essential part of protecting public health for decades. However, despite the overwhelming evidence for their effectiveness and safety, there has been an increasing trend of vaccine hesitancy in recent years. What is vaccine hesitancy? Are there any long-term risks with vaccines?